close-button

Sign in

Forgot Password?



Not signed up yet? Sign up now

close-button

Sign up for new account

IBPS Bank PO and Clerk Exam Preparation
IBPS SO
IBPS Bank PO and Clerk Exam Preparation
IBPS PO
IBPS Bank PO and Clerk Exam Preparation
IBPS Clerk
IBPS Bank PO and Clerk Exam Preparation
GMAT
IBPS Bank PO and Clerk Exam Preparation
SSC CGL-1
Railways (RRB) Preparation
Railway(RRB)


Already a member? Sign in now

close button

Forgot Password?



Remember your password? Sign in now

 

Natco Pharma gets DCGI nod to sell hepatitis C treatment drug

medicines-l-reutersDrug major Natco PharmaBSE -0.52 % has got approval from the Drugs Controller General of India (DCGI) to sell generic version of Daclatasvir, which is used for treatment of chronic hepatitis C.

In a BSE filing today, Natco Pharma said: “It is the first company in India to get approval for generic Daclatasvir Dihydrochloride (Daclatasvir) tablets, 30 mg & 60 mg, from the Drugs Controller General (India).”

Daclatasvir is the first-in-class NS5A inhibitor used in combination with Sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) genotype 3 infection. Read More

Comment Here

Leave a Reply

Download our Android app to Study Anywhere, Anytime

Studycopter's Android App is used by thousands of users to practice & study for IBPS prelim and mains exams for PO, Clerk, and SO. Get it now to get a top IBPS exam score

TeacherDownload

Like our Facebook page to get exam updates, current affairs, exam tips etc.

Teacher